Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/25/2015 06/26/2015 06/29/2015 06/30/2015 07/01/2015 Date
77.35(c) 76.47(c) 76.05(c) 77.43(c) 79.79(c) Last
901 267 2 010 128 660 062 885 441 766 459 Volume
-2.20% -1.14% -0.55% +1.81% +3.05% Change
More quotes
Financials ($)
Sales 2015 72,5 M
EBIT 2015 -48,6 M
Net income 2015 -51,1 M
Debt 2015 18,5 M
Yield 2015 -
Sales 2016 115 M
EBIT 2016 -10,7 M
Net income 2016 -12,7 M
Debt 2016 6,79 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 47,0x
EV / Sales 2016 29,6x
Capitalization 3 388 M
More Financials
Company
Anacor Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered seven compounds that are currently in development including its... 
More about the company
Surperformance© ratings of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ANACOR PHARMACEUTICALS INC
06/29 ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial S..
06/29 ANACOR PHARMACEUTICALS : Announces Amendment to KERYDIN Commercialization Agreem..
06/25 ANACOR PHARMACEUTICALS : ANAC) is Trading Lower on Unusual Volume for June 25
06/11 ANACOR PHARMACEUTICALS : Names Graeme Bell as New Executive Vice President and C..
06/11 ANACOR PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (fo..
06/03 ANACOR PHARMACEUTICALS : Change in Directors or Principal Officers, Regulation F..
06/01 ANACOR PHARMACEUTICALS : Names Graeme Bell as New Executive Vice President and C..
05/27 ANACOR PHARMACEUTICALS : to Present at Upcoming Investor Conferences
More news
Sector news : Biotechnology & Medical Research - NEC
04:06p QUINTILES TRANSNATIONAL : ’ Second Quarter 2015 Earnings Call Scheduled fo..
06/30 ISIS PHARMACEUTICALS : Webcast Alert: Corporate Presentation at the 2015 Isis Ph..
06/29DJCelgene to Pay Juno $1 Billion as Part of 10-Year Collaboration
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/01 New finance chief at Anacor Pharma
05/06 Anacor Pharmaceuticals' (ANAC) CEO Paul Berns on Q1 2015 Results - Earnings C..
05/06 Anacor Pharmaceuticals (ANAC) Q1 2015 Results - Earnings Call Webcast
05/06 Anacor Pharmaceuticals beats by $0.19, beats on revenue
05/05 Notable earnings after Wednesday's close


Comments 
Advertisement
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions